Luoxin Pharmaceutical disclosed that part of the shares held by three Deyi-affiliated partnerships, which together hold more than 5% of the company, have been judicially frozen. The total frozen shares amount to 9.2413 million shares, representing 15.74% of the combined holdings of the four shareholders and 0.85% of the company's total share capital. The freeze commenced on August 5, 2026, and will expire on June 15, 2029. The company stated that the freeze will not have a material impact on its governance or daily operations, nor will it lead to a change in control. However, if enforced, it may trigger passive share reductions. The Deyi-affiliated shares originated from a major asset restructuring in 2019. The four shareholders together hold 5.40% of the company, and none of them are controlling shareholders or actual controllers.
Luoxin Pharmaceuticals Group Stock Co LtdJudicial freeze on 0.85% of shares may lead to passive reductions, though company says no material impact.
